Beryl Drugs Standalone June 2024 Net Sales at Rs 6.25 crore, down 22.9% Y-o-Y
August 13, 2024 / 12:10 IST
Reported Standalone quarterly numbers for Beryl Drugs are:Net Sales at Rs 6.25 crore in June 2024 down 22.9% from Rs. 8.11 crore in June 2023.
Quarterly Net Profit at Rs. 0.37 crore in June 2024 down 30.62% from Rs. 0.53 crore in June 2023.
EBITDA stands at Rs. 0.98 crore in June 2024 down 13.27% from Rs. 1.13 crore in June 2023.
Beryl Drugs EPS has decreased to Rs. 0.73 in June 2024 from Rs. 1.05 in June 2023.
| Beryl Drugs shares closed at 29.74 on August 12, 2024 (BSE) and has given -8.72% returns over the last 6 months and 46.86% over the last 12 months. |
| Beryl Drugs | | Standalone Quarterly Results | in Rs. Cr. |
|
| Jun'24 | Mar'24 | Jun'23 | | Net Sales/Income from operations | 6.25 | 2.98 | 8.11 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 6.25 | 2.98 | 8.11 | | EXPENDITURE | | Consumption of Raw Materials | 3.36 | 2.88 | 3.50 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 0.09 | 0.14 | 0.09 | | Power & Fuel | -- | -- | -- | | Employees Cost | 0.50 | 0.49 | 0.44 | | Depreciation | 0.28 | 0.32 | 0.28 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 1.35 | -0.33 | 3.01 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 0.67 | -0.52 | 0.79 | | Other Income | 0.04 | 0.23 | 0.07 | | P/L Before Int., Excpt. Items & Tax | 0.70 | -0.29 | 0.85 | | Interest | 0.21 | 0.13 | 0.12 | | P/L Before Exceptional Items & Tax | 0.50 | -0.42 | 0.73 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 0.50 | -0.42 | 0.73 | | Tax | 0.13 | -0.08 | 0.20 | | P/L After Tax from Ordinary Activities | 0.37 | -0.35 | 0.53 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 0.37 | -0.35 | 0.53 | | Equity Share Capital | 5.07 | 5.07 | 5.07 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 0.73 | -0.68 | 1.05 | | Diluted EPS | 0.73 | -0.68 | 1.05 | | EPS After Extra Ordinary | | Basic EPS | 0.73 | -0.68 | 1.05 | | Diluted EPS | 0.73 | -0.68 | 1.05 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
